
On March 19, the “Medical Path to Growth, Joint Success” Healthcare Partnership Innovation Collaboration Scheme Competition, co-hosted by four industry-leading companies from different sectors—Pfizer China, Ping An Insurance, Tencent, and Legend Capital, and strongly supported by the Bill & Melinda Gates Foundation, WeDoctor Group, DXY, and United Family Healthcare, concluded in Beijing.
The Medical Partner Competition lasted nearly 90 days, with close to 400 project registrations. Ultimately, Mingyi Zhudao and Aier Times jointly won the Service Category Championship (with identical scores up to three decimal places). Tumor Catcher secured the Technology Category Championship and also received the Most Publicly Attended Award. Dana Biotech was awarded the Most Innovative Value Award, while New Horizon Health received the Most Medical Value Award.
As a co-organizer, VCBeat participated in the Medical Partner Competition throughout its entire course. We were deeply impressed by the professionalism, influence, and determination of the four main organizers—Pfizer China, Ping An Insurance, Tencent, and Legend Capital—to drive improvements in China’s healthcare sector. Even more moving was the dedication of nearly 400 healthcare entrepreneurs, who have made significant efforts and contributions in such a complex and challenging field, demonstrating a strong desire for resource sharing and collaboration.
For this very reason, although the current Medical Partners Competition has concluded, the four organizing parties remain unwavering in their commitment to integrating global resources and fostering the better development of China’s healthcare sector. These “Big Four” have also adopted a new identity known as “Mr. PPT,” positioning themselves as one of the most significant forces driving medical innovation in China’s future.
Let’s take a look with VCBeat at what exactly unfolded in the Grand Finals of the Medical Partners Competition.
What Kind of Entrepreneurs Can Become Champions?
VCBeat has previously reported that among nearly 400 applicant companies, internet healthcare firms accounted for almost half. Among the eventual winners, internet healthcare companies also made up half, primarily consisting of service-oriented providers, while the other half were mainly technology-focused enterprises.
Service Category Champion: Renowned Surgeon
Mingyi Zhudao is China’s largest mobile surgical platform, dedicated to providing professional, efficient, and safe surgical services to patients in need, facilitating appointments with renowned specialists for their procedures. Headquartered in Shanghai with branches in multiple cities, its operations cover the entire country. The platform aggregates top-tier medical experts from both domestic and international sources, as well as underutilized hospital bed capacity. By leveraging internet technology, it achieves precise matching between patients and physicians and optimizes the allocation of medical resources, effectively addressing patients’ practical needs for accessible and high-quality care.
Service Category Champion:EarCare Era
Aier Times is China’s largest hearing healthcare platform. Founded in 2013, it is dedicated to building an international, high-quality brand for hearing healthcare services, integrating superior professional hearing resources both domestically and abroad, and meeting the hearing care needs of individuals with hearing impairment in China. Leveraging international training backgrounds and globally recognized credentials, Aier Times audiologists focus on providing one-stop, comprehensive, and professional hearing solutions for Chinese families.
Technical Category Champion:“Tumor Catcher”
Zhongke Natai is a nanobiotechnology company dedicated to advancing liquid biopsy technologies. Leveraging the scientific research strength of the National Center for Nanoscience and Technology, Chinese Academy of Sciences, and building on nanotechnologies characterized by “high-throughput,” “microfluidics,” and “microarrays,” the company continuously develops medical products with independent intellectual property rights, providing services for early tumor diagnosis and precision medicine research. Its “Tumor Hunter” technology, which uses peptide-coated magnetic nanoparticles to detect circulating tumor cells (CTCs) in peripheral blood, has won numerous awards both domestically and internationally.
To find out which companies ultimately won the grand prizes, please click"Medical Partner" Champion AnnouncedMeanwhile, VCBeat will continue to report on the shortlisted companies. Stay tuned.
What Does "PPT Jun" Mean? Carrying Medical Partnerships Through to the End
At the grand finale of the Medical Partners competition, Dr. Wu Xiaobin, President of Pfizer China, introduced a new term: “PPT Jun,” representing Pfizer China, Ping An Insurance, Tencent, and Legend Capital. The collaboration among these leading enterprises from four major sectors has created a spectacular showcase for medical innovation and entrepreneurship in China. Yet this is not the end but merely the beginning; the introduction of “PPT Jun” marks the start of these four companies’ vision for future cooperation.
At the afternoon roundtable forum featuring direct dialogue among the four main organizers, themed “Taking ‘Partnership’ to the End,” Pfizer China President Wu Xiaobin, Zhang Lin, Deputy General Manager of Ping An Pension Insurance, Mu Yifei, Executive Director of Tencent Investment, and Ouyang Xiangyu, Managing Director of Legend Capital, all stated that they would maintain the “PPT Jun” initiative, continue to strengthen the integration of healthcare resources, and create a more favorable environment for medical innovation and entrepreneurship in China.
In fact, as the competition progressed, the Medical Partner initiative ceased to be merely an endeavor of four companies. Numerous industry leaders, including the Bill & Melinda Gates Foundation, WeDoctor Group, DXY, and United Family Healthcare, have been gravitating toward the Medical Partner platform.
Key Highlights from the Roundtable Discussion:
1. In fact, physicians have many valuable ideas; we hope to see greater physician participation in future Medical Partner events.
2. The business model is the key to integrating healthcare, pharmaceuticals, and insurance.
3. Tencent prefers to invest in companies that can continuously generate precise or scalable data.
4. I believe that PPT Jun will be a long-standing forum and will play a significant role in the transformation and reform of our country's healthcare system.
See what the four industry leaders have to say, explore collaboration opportunities, and learn how future healthcare partnerships will evolve. Click here.Going All In on “Partnership”: A Dialogue with PPT Jun Dalao!Packed with valuable insights.
There is still much more content waiting for you.
There’s so much valuable content to digest. Click hereRead the original article, you will see continuous updates on the following content:
1. Dean's Dialogue with Entrepreneurs
Following Wang Shan, former president of Peking University People’s Hospital, another distinctive hospital leader, Liu Yucun, president of Peking University First Hospital, participated in the Medical Partners Roundtable Forum. Two of his viewpoints drew significant attention: first, he explicitly disagreed with a one-size-fits-all approach to restricting physicians’ collaborations with mobile health platforms; second, he noted that public hospitals are currently more receptive to public-welfare-oriented partnerships, while remaining highly sensitive to commercial collaborations.
Pan Zhongying, President of United Family Healthcare, a renowned private hospital, expressed openness to collaborating with internet healthcare companies.
Meanwhile, Wang Hang, CEO of Haodf, and Liao Jieyuan, CEO of WeDoctor Group, as representatives of internet healthcare companies, participated in the dialogue.
In short, there is a wealth of information. VCBeat will subsequently release the detailed content of the dialogue between the hospital director and the president of the internet company.
2、DXY Founder Li Tiantian’s Speech: Managing Chronic Diseases with “Data + Services”
Li Tiantian's Core Views:
1. The optimal use cases for mobile health are in home settings or primary care institutions;
2. Data is captured through technology, while services are manifested through interaction;
3. The Optimal Approach to Chronic Disease Management: Data + Services;
4. More pharmaceutical companies are adopting a “patient-centric” approach;
5. In the healthcare industry, one must remain composed and patient in refining high-quality products.
To view Li Tiantian’s detailed presentation, please click:Li Tiantian:Chronic Disease Management with “Data + Services”
Links to the Medical Partner Series Reports, Continuously Updated:
“Medical Partner” Champion Announced
Going All-In on “Partnership”: A Conversation with PPT Jun, the Industry Leader!
Li Tiantian:Managing Chronic Diseases with "Data + Services"
Final Note: Given the wealth of practical insights shared by our Medical Partners, we will continue to release follow-up content. Meanwhile, VCBeat will also provide coverage on the selected startups. Most importantly, we hope to join forces with entrepreneurs, pitch deck creators, and all colleagues concerned with the development of China’s healthcare sector, working together to make healthcare in China better.